Improving Treatments - Improving Lives

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis' unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.



LATEST RELEASES

Apr 10, 2015
Warrant Programme - New Articles of Association

Mar 27, 2015
Veloxis Pharmaceuticals A/S establishes new Warrant Programme

Mar 27, 2015
Warrant Programme - Veloxis Pharmaceuticals A/S issues new shares in connection with exercise of warrants

Mar 26, 2015
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting

Stock Information

QUICK LINKS